Elevation of plasma levels of secreted type IIa phospholipase A2 as an independent factor of low high-density-lipoprotein3-cholesterol in human

被引：0
|
作者：
Kawashiri, M [1 ]
Mizuno, M [1 ]
Tsuchida, M [1 ]
Takata, M [1 ]
Katsuda, S [1 ]
Miwa, K [1 ]
Nohara, A [1 ]
Inazu, A [1 ]
Kobayashi, J [1 ]
Koizumi, J [1 ]
Mabuchi, H [1 ]
Yamagishi, M [1 ]
机构：
[1] Kanazawa Univ, Kanazawa, Ishikawa 920, Japan
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2006年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E66 / E66
页数：1
相关论文
共 50 条
  • [1] LOW PREVALENCE OF ELEVATED LEVELS OF LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 MASS OBSERVED AMONG PERSONS WITH INCREASED LEVELS OF HIGH DENSITY LIPOPROTEIN CHOLESTEROL
    Reddy, K.
    Singh, M.
    Bangit, J.
    Batsell, R.
    Zaheer, M.
    Wegner, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [2] Regulation of lipoprotein associated phospholipase A2 by platelet activating factor and oxidized low density lipoprotein
    Griffiths, R
    Lin, J
    van Antwerpen, R
    Schenkein, HA
    Tew, JG
    Barbour, SE
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E78 - E78
  • [3] EFFECTS OF PHENYTOIN ON PLASMA HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS IN MEN WITH LOW-LEVELS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL
    GOERDT, C
    KEITH, M
    RUBINS, HB
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (08): : 767 - 775
  • [4] Expression of Human Secretory Group IIA Phospholipase A2 is Associated with Reduced Concentrations of Plasma Cholesterol in Transgenic Mice
    Mario Menschikowski
    Rolf Eckey
    Jens Pietzsch
    Johannes Aufenanger
    Rainer Kumpf
    Peter Nelz
    Werner Jaross
    Inflammation, 2000, 24 : 227 - 237
  • [5] Low levels of high density lipoprotein cholesterol in Turkish children: An important risk factor
    Iscan, A
    Yigitoglu, MR
    Vurgun, N
    Uyanik, BS
    Akyildiz, M
    ACTA PAEDIATRICA JAPONICA, 1998, 40 (01): : 41 - 46
  • [6] Expression of human secretory group IIA phospholipase A2 is associated with reduced concentrations of plasma cholesterol in transgenic mice
    Menschikowski, M
    Eckey, P
    Pietzsch, J
    Aufenanger, J
    Kumpf, R
    Nelz, P
    Jaross, W
    INFLAMMATION, 2000, 24 (03) : 227 - 237
  • [7] Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia
    Davidson, M
    Ma, P
    Stein, EA
    Gotto, AM
    Raza, A
    Chitra, R
    Hutchinson, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (03): : 268 - 275
  • [8] ZD4522 is superior to atorvastatin in decreasing low density lipoprotein cholesterol and increasing high density lipoprotein cholesterol in patients with type IIa or IIb hypercholesterolemia
    Davidson, MH
    Ma, PTS
    Stein, E
    Hutchinson, HG
    Chitra, R
    Raza, A
    Gotto, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 292A - 292A
  • [9] IS LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN HIGH DENSITY LIPOPROTEIN A RISK FACTOR FOR CORONARY VASCULAR DISEASE IN THE ELDERLY?
    Caslake, M.
    Cooney, J.
    Murray, E.
    Bedford, D.
    Roberston, M.
    Packard, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] Circulating secretory type IIA phospholipase A2, lipoprotein (a) and soluble cellular adhesion molecule levels in patients with angina pectoris
    Ao, Caihui
    Qi, Litong
    Xiong, Zhuowei
    Kang, Aichun
    Guo, Hongyi
    Xue, Lin
    Huo, Yong
    CLINICAL BIOCHEMISTRY, 2008, 41 (18) : 1423 - 1428
12345